Redeye states that Gapwaves delivered a solid report with beats across key metrics. Valeo reached start of production on 1 July, which should accelerate growth hereon, albeit from low volumes. Gapwaves is inching closer to delivering on existing volume agreements, making it a compelling entry for long-term shareholders as improving results driven by Tier 1 volumes should buoy the share. Additionally, a "conveyor belt of catalysts" is present with those in the development phase transitioning to volume agreements prior to start of production.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/